Sanofi has pulled back the curtain on its plans for R&D in the post-Chris Viehbacher future, outlining a deeply intertwined relationship with German outsourcer Evotec designed to help the company cut costs as it shares the risks and rewards of building out its pipeline.

…read more

Source: Sanofi cozies up to Evotec in a cross-cutting $310M R&D alliance


0 No comments